232 Hormonal Intrauterine device 0 (0.0%) 3 (5.0%) 1 (1.2%) 0 (0) GnRH Antagonist 3 (9.1%) 9 (15.0%) 12 (14.1%) 0 (0) Endometriosis surgery 9 (27.3%) 30 (50.0%) 38 (44.7%) 0 (0) 0.0803 Endometriosis Type*** Deep invasive Endometriosis Endometriomas Superficial Plaques 0 (0) 0 (0) 0 (0) 18 (30.0%) 32 (52.4%) 29 (47.5%) 23 (24.7%) 52 (55.9%) 50 (53.7%) 0 (0) 0 (0) 0 (0) 0.6613 0.3643 0.2123 Adenomyosis Type Focal Diffuse Cystic Combined Focal + Cystic Combined Diffuse + Cystic Unclear**** 16 (44.4%) 5 (13.9%) 0 (0) 5 (13.9%) 5 (13.9%) 5 (13.9%) 0 (0) 0 (0) 0 (0) 0(0) 0 (0) 0 (0) 42 (45.1%) 26 (27.9%) 5 (5.5%) 12 (12.9%) 5 (5.5%) 3 (3.2%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0(0) 0.1623 For normally distributed variables, values are depicted as Mean, standard deviation (SD) and for abnormally distributed variables as Median, Interquartile range (IQR). 1 = One-Way ANOVA, 2 = Kruskal-Wallis Test, 3 = Chi-square Test. Subscript letters denote significant differences between groups with different letters * Primary subfertility are women/couples who are nulliparous, and secondary subfertility involves women/couples who are multiparous. **Percentages can add up to >100% as patients could have multiple IVF/ICSI treatment indications simultaneously ***Total number of patients is greater than the group size as patients could have presence of different types of endometriosis simultaneously (i.e. endometriomas and superficial plaques) **** Unclear adenomyosis type was assigned in cases whereby the imaging quality was insufficient, or the uterus was too abnormal to be able to accurately assess adenomyosis subtype
RkJQdWJsaXNoZXIy MTk4NDMw